文献
J-GLOBAL ID:201702258781316988
整理番号:17A1191458
軽度から中等度の持続性喘息(BISE)患者のためのBenralizumab:無作為化,二重盲検,プラセボ対照,第3相試験【Powered by NICT】
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
著者 (11件):
Ferguson Gary T
(Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA)
,
FitzGerald J Mark
(The Lung Centre, Vancouver General Hospital, University of British Columbia Institute for Heart and Lung Health, Vancouver, BC, Canada)
,
Bleecker Eugene R
(Wake Forest School of Medicine, Winston-Salem, NC, USA)
,
Laviolette Michel
(Institut de Cardiologie et de Pneumologie de Quebec, QC, Canada)
,
Bernstein David
(Bernstein Clinical Research Center LLC, Cincinnati, OH, USA)
,
LaForce Craig
(North Carolina Clinical Research, Raleigh, NC, USA)
,
Mansfield Lyndon
(Western Sky Medical Research Inc., El Paso, TX, USA)
,
Barker Peter
(AstraZeneca, Gaithersburg, MD, USA)
,
Wu Yanping
(AstraZeneca, Gaithersburg, MD, USA)
,
Jison Maria
(AstraZeneca, Gaithersburg, MD, USA)
,
Goldman Mitchell
(AstraZeneca, Gaithersburg, MD, USA)
資料名:
Lancet Respiratory Medicine
(Lancet Respiratory Medicine)
巻:
5
号:
7
ページ:
568-576
発行年:
2017年
JST資料番号:
W3111A
ISSN:
2213-2600
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)